Evaluation of the Health Care Homes Program

Page last updated: 10 August 2022

Health Policy Analysis (HPA) has worked with experts from the University of NSW and the University of Technology evaluate the Health Care Homes trial.

The evaluation aimed to:

  • identify the changes in structure and processes that occurred following the rollout of the trial
  • measure short-term outcomes
  • provide preliminary evidence concerning the medium to longer-term outcomes.

The key evaluation questions were:

  • How was the Health Care Homes model implemented and what were the barriers and enablers?
  • How does the Health Care Homes model change the way practices approach chronic disease management?
  • Do patients enrolled in Health Care Homes experience better quality care?
  • What are the financial effects of the Health Care Homes model on governments, providers and individuals?

The evaluation collected quantitative and qualitative data from participating practices and patients through:

  • automated extracts of de-identified data from practice clinical software, including:
    • information on patient demographics
    • clinical encounters
    • chronic illnesses
    • prescriptions
    • pathology and imaging tests
    • risk factors (smoking/alcohol)
  • practice surveys and practice staff surveys
  • practice staff face-to-face interviews
  • patient surveys, interviews and focus groups.

The evaluation also used national administrative data sets (including Medicare Benefits Schedule, Pharmaceutical Benefits Scheme, emergency department attendances and hospitalisation) to compare the use of health services for patients enrolled in the Health Care Homes trial with a matched comparison group receiving usual care.

Evaluation results and lessons learned will be used to inform future primary care reform.

See the evaluation reports.

In this section